FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
23/11/2024
Voltar para busca
Dado oficial do USPTO
HISTOCYTE LABORATORIES
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
HISTOCYTE LABORATORIES
ST13
US500000079342045Classe
1, 5
Pedido
79342045
Registro
7383168
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
52
Atualização mais recente
23/11/2024
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 5
Data de depósito
08/12/2021
Data de registro
14/05/2024
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
14/05/2024
Última transação
14/05/2024
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
99
Localização do titular
GB
Examinador
BLAKESLEE, RICHARD A
Unidade examinadora
N50
Localização atual
FILE REPOSITORY (FRANCONIA)
Titulares e representantes
Titulares
HistoCyte Laboratories Ltd
Representantes
Mari-Elise Paul McBrayer PLLC
Classificação técnica
Classes Nice
Classe 1Classe 5
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
diagnostic chemicals other than for medical or veterinary purposes; chemical reagents for use in diagnostic tests other than for medical or veterinary purposes; chemical reagents for use in diagnostic testsother than for medical or veterinary use; reagents for laboratory purposes other than for medical or veterinary purposes; diagnostic reagents for in-vitro use other than medical or veterinary purposes; diagnostic chemical and biological reagents used for molecular testing for clinical diagnosticsother than for medical or veterinary use; chemical substances for analyses in laboratoriesother than for medical or veterinary purposes; reagents for scientific purposes; reagents for medical research; reagents for research purposes; diagnostic reagents for scientific or research use; diagnostic testing materialsother than for medical use; diagnostic preparations for scientific or research use
Classe 5
Medical diagnostic reagents; clinical diagnostic reagents for medical use; reagents for medical use; diagnostic reagents for medical use; biological reagents for medical use; chemical diagnostic reagents for medical use; diagnostic biomarker reagents for medical purposes; reagents for analytical purposes for medical purposes; reagents for in-vitro laboratory use for medical purposes; reagents for use in diagnostic tests for medical purposes; biological tissue cultures for medical purposes; diagnostic agents for medical use; in vitro diagnostic preparations for medical use
Publicações
Histórico de despachos e eventos da marca no USPTO.
52 publicações encontradas
FICS
FINAL DISPOSITION NOTICE SENT TO IB
06/11/2024
FIMP
FINAL DISPOSITION PROCESSED
06/11/2024
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
14/08/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
14/05/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
14/05/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
10/04/2024
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
10/04/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/04/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/04/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/03/2024
PUBO
PUBLISHED FOR OPPOSITION
27/02/2024
GPNX
NOTIFICATION PROCESSED BY IB
26/02/2024
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
07/02/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/02/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/02/2024
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
07/02/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
19/01/2024
XAEC
EXAMINER'S AMENDMENT ENTERED
19/01/2024
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
19/01/2024
GNEA
EXAMINERS AMENDMENT E-MAILED
19/01/2024
CNEA
EXAMINERS AMENDMENT -WRITTEN
19/01/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
22/12/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
22/12/2023
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
22/12/2023
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
03/12/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
15/11/2023
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
15/11/2023
RDX3
NOTIFICATION FOR REQ FOR RECON DENIED NO APPEAL FILED
02/10/2023
RDX1
ACTION FOR REQ FOR RECON DENIED NO APPEAL FILED E-MAILED
02/10/2023
RRDX
ACTION REQ FOR RECON DENIED NO APPEAL FILED COUNTED NOT MAILED
02/10/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/09/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/09/2023
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
11/09/2023
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
23/06/2023
GNFR
FINAL REFUSAL E-MAILED
23/06/2023
CNFR
FINAL REFUSAL WRITTEN
23/06/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
26/05/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
25/05/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
25/05/2023
ATRV
ATTORNEY REVIEW COMPLETED
11/05/2023
LIME
LIMITATION FROM THE IB - REQUEST EXAM REVIEW
03/05/2023
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
06/02/2023
RFNT
REFUSAL PROCESSED BY IB
22/12/2022
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
25/11/2022
RFRR
REFUSAL PROCESSED BY MPU
25/11/2022
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
17/09/2022
CNRT
NON-FINAL ACTION WRITTEN
16/09/2022
DOCK
ASSIGNED TO EXAMINER
16/09/2022
MAFR
APPLICATION FILING RECEIPT MAILED
14/06/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/06/2022
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
09/06/2022
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace HISTOCYTE LABORATORIES ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.